Search Results - "FAGERLAND, S"
-
1
On-line detection of extracellular levels of serotonin in dorsal raphe nucleus and frontal cortex over the sleep/wake cycle in the freely moving rat
Published in Neuroscience (01-01-1998)“…We used in vivo microdialysis coupled with polygraphic recording to monitor 5-hydroxytryptamine levels in the dorsal raphe nucleus and frontal cortex across…”
Get full text
Journal Article -
2
Pathological pigmentation in cardiac tissues of Atlantic salmon (Salmo salar L.) with cardiomyopathy syndrome
Published in Veterinary research (Paris) (13-11-2013)“…It is widely accepted that melanin formation may play an immunologic role in invertebrates and ectothermic vertebrates. In farmed Atlantic salmon,…”
Get full text
Journal Article -
3
The reliability and functional validity of visual and semiautomatic sleep/wake scoring in the Møll-Wistar rat
Published in Sleep (New York, N.Y.) (01-03-1994)“…The present paper has three major objectives: first, to document the reliability of a published criteria set for sleep/wake scoring in the rat; second, to…”
Get full text
Journal Article -
4
EEG Power Densities (0.5–20 Hz) in Different Sleep–Wake Stages in Rats
Published in Physiology & behavior (01-02-1998)“…Bjorvatn, B., S. Fagerland and R. Ursin. EEG power densities (0.5–20 Hz) in different sleep–wake stages in rats. PHYSIOL BEHAV 63(3) 413–417,…”
Get full text
Journal Article -
5
Sleep/waking effects of a selective 5-HT1A receptor agonist given systemically as well as perfused in the dorsal raphe nucleus in rats
Published in Brain research (03-10-1997)“…Sleep/waking stages and behavior were studied following the selective 5-HT1A agonist 8-OH-DPAT given subcutaneously (s.c.) (0.010-0.375 mg/kg) as well as…”
Get full text
Journal Article -
6
Sleep/waking effects of a selective 5-HT sub(1A) receptor agonist given systemically as well as perfused in the dorsal raphe nucleus in rats
Published in Brain research (01-10-1997)“…Sleep/waking stages and behavior were studied following the selective 5-HT1A agonist 8-OH-DPAT given subcutaneously (s.c.) (0.010-0.375 mg/kg) as well as…”
Get full text
Journal Article